Dimensional Fund Advisors LP Neoleukin Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.69 - $1.33 $7,740 - $14,919	-11,218 Reduced 51.98%	10,365 $7,000
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $13,519 - $41,107	-7,860 Reduced 26.7%	21,583 $41,000
Q4 2021 Feb 09, 2022	BUY	$4.65 - $7.75 $29,299 - $48,832	6,301 Added 27.23%	29,443 $142,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $9.66 $84,718 - $135,268	-14,003 Reduced 37.7%	23,142 $167,000
Q2 2021 Aug 12, 2021	BUY	$9.23 - $13.12 $207,555 - $295,029	22,487 Added 153.41%	37,145 $343,000
Q1 2021 May 14, 2021	SELL	$11.26 - $15.78 $2.58 Million - $3.61 Million	-228,738 Reduced 93.98%	14,658 $180,000
Q4 2020 Feb 25, 2021	BUY	$10.17 - $14.56 $2.48 Million - $3.54 Million	243,396 New	243,396 $3.43 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.